Structure Therapeutics Inc ADR [GPCR] stock prices are up 4.73% to $28.34 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GPCR shares have gain 12.64% over the last week, with a monthly amount drifted -9.97%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Structure Therapeutics Inc ADR [NASDAQ: GPCR] stock has seen the most recent analyst activity on January 08, 2025, when Stifel initiated its Buy rating and assigned the stock a price target of $50. Previously, H.C. Wainwright started tracking the stock with Buy rating on December 04, 2024, and set its price target to $80. On September 23, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $118 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $65 on May 21, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $65 as its price target on April 09, 2024. JMP Securities started tracking with a Mkt Outperform rating for this stock on October 19, 2023, and assigned it a price target of $90. In a note dated July 27, 2023, Piper Sandler initiated an Overweight rating and provided a target price of $58 on this stock.
The stock price of Structure Therapeutics Inc ADR [GPCR] has been fluctuating between $23.50 and $62.74 over the past year. Currently, Wall Street analysts expect the stock to reach $99 within the next 12 months. Structure Therapeutics Inc ADR [NASDAQ: GPCR] shares were valued at $28.34 at the most recent close of the market. An investor can expect a potential return of 249.33% based on the average GPCR price forecast.
Analyzing the GPCR fundamentals
Gross Profit Margin for this corporation currently stands at 0.12% with Operating Profit Margin at -107.05%, Pretax Profit Margin comes in at -83.35%, and Net Profit Margin reading is -83.25%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.16 and Total Capital is -0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 27.22 points at the first support level, and at 26.10 for the second support level. However, for the 1st resistance point, the stock is sitting at 29.10, and for the 2nd resistance point, it is at 29.87.
Ratios To Look Out For
It’s worth pointing out that Structure Therapeutics Inc ADR [NASDAQ:GPCR]’s Current Ratio is 27.63. As well, the Quick Ratio is 27.63, while the Cash Ratio is 5.15.
